跳至主要内容
临床试验/NCT03216863
NCT03216863终止不适用

Home Respiratory Rehabilitation in Patients With Lung Cancer Non-small Cell Advanced or Metastatic Treated With Oral Targeted Therapy

University Hospital, Lille3 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2015年8月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
25
试验地点
3
主要终点
Rate of patients completing the full Respiratory Rehabilitation (8 weeks) at home

研究概览

简要总结

The feasibility and impact of respiratory rehabilitation (RR) in patients with advanced or metastatic (EGF-R WT or mutated) non-small cell lung cancer treated with oral targeted therapy including Inhibitors of EGF-R tyrosine kinases (TKI) and ALK inhibitors.

These patients will benefit, at the beginning of the chemotherapy whatever the treatment line, of a respiratory rehabilitation. The respiratory rehabilitation takes place at the patient's home with the HAD's cooperation 3 hours per week, divided into 2 or 3 sessions. There is associated educational, nutritional and psychological support for a total duration of 8 weeks.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with advanced or metastatic lung cancer
  • In the course of treatment by oral chemotherapy of oral targeted therapy (tyrosine kinase inhibitor) in 1st, 2nd, 3rd line or more at the time of their inclusion
  • Diagnosis of CP retained after multidisciplinary discussion of patient records

排除标准

  • Any residual toxicity of a previous antineoplastic treatment, grade>
  • Cardio-respiratory contraindications to exercise re-training:
  • Angina unstable
  • Recent infarct
  • Tight aortic stenosis
  • Unsteady heart failure
  • Pericarditis, endocarditis, myocarditis
  • Evolutionary thromboembolic disease
  • Ventricular aneurysm
  • Intra ventricular thrombus
  • Uncontrolled rhythm disorders
  • Instability of the respiratory state defined by uncompensated respiratory acidosis
  • Carcinological contraindications:
  • Bone metastases at risk of fracture and / or algae despite optimal analgesic treatment, symptomatic central nervous system metastases
  • Presence of anemia (Hb <8g / dl or <10g / dl if patient with previous cardiac history), thrombocytopenia (<100,000 platelets / mm3)
  • Chimio toxicity (neurological, cardiac) according to the investigator's assessment
  • Neuromuscular contraindications:
  • Neuromuscular and / or osteo-articular disease making it impossible to re-train
  • Severe cognitive impairment
  • Patient under tutorship or curatorship

研究组 & 干预措施

8 weeks Respiratory rehabilitation

Experimental

干预措施: Respiratory rehabilitation (Other)

结局指标

主要结局

Rate of patients completing the full Respiratory Rehabilitation (8 weeks) at home

时间窗: At 8 weeks

次要结局

  • Functional capacity(Baseline and 8 weeks)
  • Body Mass Index(Baseline and 8 weeks)
  • EORTC QLQ C-30 standardized version 3.0(Baseline and 8 weeks)
  • Overall and progression-free survival(at 6 months)
  • Respiratory capacity(Baseline and 8 weeks)
  • Functional Assessment of Cancer Therapy Lung standardized(Baseline and 8 weeks)
  • Nutritional Risk Screening score(Baseline and 8 weeks)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验